habe ich den untenstehenden Text auf einer objektiven Seite im Netz, die alle möglichen Firmen beschreibt die mit Nabelschnurblut arbeiten.
Dabei geht es lediglich darum Eltern über die Möglichkeiten aufzuklären die diese Einlagerungen jeweils ermöglichen können.
Die Seite wurde wohl nach dem Verlust des eigenen Kindes erstellt.
Die Beschreibung von CBAI ist nur eine von vielen Firmen die beschrieben werden.
Cord Blood America (includes CorCell)
INTERNET: www.cordblood-america.com
PHONE: 888-326-7235 (888-3-CORCELL)
OFFICE: Las Vegas, NV and Philadelphia, PA
STORAGE: Progenitor Cell Therapy, Hackensack, NJ
ACCREDITATION: AABB, NJ, NY
COMMENT: Cord Blood America is a publicly held (Nasdaq OTCBB:CBAI) holding company which operates its cord blood business through CorCell Companies, Inc. of Philadelphia.
SERVICES & DISCOUNT OPTIONS:
•Cord blood collections are processed at the laboratory of Progenitor Cell Therapy. The transplant quota is mostly cord blood units released for transplants through public registries. However, Corcell has released 7 units from family storage for transplant (6 to the donor child and 1 to a sibling).
•Progenitor Cell Therapy processing uses sedimentation with hetastarch to separate MonoNuclear Cells from cord blood. Bags are used for both the blood collection and the final storage of the processed cells.
•Progenitor Cell Therapy laboratory has both FACT and AABB accreditation and follows cGMP (ie: cellular GMP) standards, which are above FDA requirements for cord blood processing.
•Live customer support is available 24/7; parents or physician can phone during delivery.
•Current (Nov. 2009) fees are $150 enrollment, $150 courier transport, $1650 collection and processing, and $125 annual storage, for a total first year fee of $2075.
•Payment plans are available.
ADDITIONAL INFORMATION:
The story of Cord Blood America begins with the cord blood bank Cord Partners, founded in 2003. Cord Partners was a marketing company with offices in Los Angeles that used the cord blood laboratory of Community Blood Services in NJ. On 28Jan2005, Cord Partners went public as part of the holding company "Cord Blood America" (Nasdaq OTCBB:CBAI).
On 28 Jan 2006, Cord Blood America purchased the assets of the cord blood bank Cryobank for Oncologic and Reproductive Donors (CORD) in Middletown, NY. The 750 cord blood collections in storage and three dewars belonging to CORD were moved to the laboratory at Community Blood Services in NJ.
On 13 Oct 2006, Cord Blood America acquired CorCell, a Philadelphia company which has been marketing family cord blood storage since 1996. In July 2004, CorCell had merged with the German cord blood bank VITA34, under a German holding company VITA34 International AG. The acquisition by Cord Blood America severed the relationship between CorCell and VITA34. Cord Blood America also purchased the CorCell inventory of approximately 10,000 cord blood collections held at the lab of Community Blood Services. However, CorCell retained its operating name. CorCell has many partnerships with health insurance companies.
On 21 Aug 2007, Cord Blood America acquired CureSource, a company headquartered in Charlestown, South Carolina which markets family cord blood storage and had recently switched its lab from the Medical University of South Carolina to Community Blood Services in NJ.
In Oct 2007, Cord Blood America stopped using the laboratory of Community Blood Services in NJ and switched to Progenitor Cell Therapy, located nearby in Hackensack NJ. As of 11/5/07, none of the old inventory has been moved. At this time, most of their cord blood banking is marketed under the name CorCell.
Progenitor Cell Therapy LLC was founded in 1997 by Andrew L. Pecora, M.D., and Robert A. Preti, Ph.D. Dr. Pecora performed the first adult transplant of expanded cord blood. Dr. Preti has been the Scientific and Laboratory Director of Hackensack University Medical Center (HUMC), located in Hackensack, New Jersey. Progenitor Cell Therapy acquired HUMC in March 1999 and upgraded it to a cGMP compliant facility which is experienced in all forms of stem cell engineering.
In 2009, Cord Blood America moved its offices, from Los Angeles CA, to Las Vegas NV, and began construction of its own laboratory in Las Vegas. The new laboratory director is Dr. Geoffrey John O'Neill, who in the past was Laboratory and Scientific/Medical Director for the famly cord blood bank Cryo-Cell International Inc. in Florida. The strategic vision of Cord Blood America is to become a "cellular pharmacy" for various types of cellular therapy.
Feeder web sites:
•www.cord-blood-stem-cells.com
•www.umbilical-cord-blood-bank.com
•www.umbilical-cord-blood-storage-banking.com
|
Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.
Zurück geht es hier.
Thread abonnieren
